Nanobiotix - ADR Forecast, price target & analysts
Nanobiotix - ADR Target price 2025 - Analyst rating & recommendation
Nanobiotix - ADR Classifications & Recommendation:
Nanobiotix - ADR Price Target
| Target Price | $10.55 |
| Price | $3.50 |
| Potential |
201.51%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Nanobiotix - ADR 2026 .
The average Nanobiotix - ADR target price is $10.55.
This is
201.51%
register free of charge
$16.61
374.47%
register free of charge
$3.50
0.02%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Nanobiotix - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Nanobiotix - ADR stock has an average upside potential 2026 of
201.51%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 32.50 | 23.51 |
| 27.65% | ||
| EBITDA Margin | -96.03% | -189.24% |
| 97.06% | ||
| Net Margin | -169.18% | -232.98% |
| 37.71% |
5 Analysts have issued a sales forecast Nanobiotix - ADR 2024 . The average Nanobiotix - ADR sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Nanobiotix - ADR EBITDA forecast 2024. The average Nanobiotix - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Nanobiotix - ADR Analysts have issued a net profit forecast 2024. The average Nanobiotix - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.16 | -1.16 |
| 32.56% | 0.00% | |
| P/E | negative | |
| EV/Sales | 6.23 |
3 Analysts have issued a Nanobiotix - ADR forecast for earnings per share. The average Nanobiotix - ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Nanobiotix - ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Nanobiotix - ADR...
Current Nanobiotix - ADR Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| STIFEL EUROPE | Locked ➜ Locked | Locked | Dec 19 2024 |
| H.C. WAINWRIGHT & CO., LLC | Locked ➜ Locked | Locked | Nov 12 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
STIFEL EUROPE: Locked ➜ Locked
|
Dec 19 2024 |
|
Locked
H.C. WAINWRIGHT & CO., LLC: Locked ➜ Locked
|
Nov 12 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
